If your trial partners are unable to quickly adapt and remain flexible, your program may be in danger of excessive delays and economic losses. PharPoint’s success is in part fueled by our willingness to be flexible in our services and rigid in our standards. We operate under the understanding that all studies and sponsors are different and require unique solutions.
We do what we do because we’re passionate about helping clients improve global health. We commonly hear that smaller sponsors, when working with a big name, globally dominating CRO, feel underappreciated and overlooked. With PharPoint’s attentive, experienced team and industry knowledge, obstacles can be addressed swiftly & transparently.
At PharPoint Research, expert attention comes standard, no matter the study or sponsor size. With every client, PharPoint ensures there are accessible lines of communication with our senior leadership, and PharPoint’s senior-most leaders, who founded the company in 2007, are still involved in operational oversight and the success of our clients.
As a company that holds honesty and transparency as a core corporate value, PharPoint goes beyond “giving updates.” We offer clients transparent and attentive communication to engage with sponsors in a way that benefits all parties. With consistent, purposeful communication, we’re able to continuously refine study processes, address challenges and concerns, and transparently provide a view of study budgets and timelines.
RELATED RESOURCES
Preparing to work with a top biometrics contract research organization and wondering how their promised data management, biostatistics, and medical writing timelines match up to the industry average? To help sponsors dig into these details and ensure the timelines they’re receiving are competitive, we’re providing PharPoint’s typical timelines alongside research that calculates industry standard timelines, when available.
Our hope is that this document can help sponsors set realistic expectations, confidently ask the right questions of their vendors, and ultimately, partner with a top biometrics CRO that keeps their study moving: because patients are waiting.
PharPoint’s short eBook, Standard Clinical Trial Timelines: A Sponsor’s Guide to Evaluating Biometrics CROs, includes the below information.
For instant access to the eBook, fill out the form below.
RELATED RESOURCES